Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Kepner

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Controlled Clinical Trials|August 10, 1999
Group sequential designs for phase II trials with historical controlsM N Chang, J J Shuster, J L Kepner
QRB. Quality Review Bulletin|February 1, 1987
Predeposit autologous blood transfusion: an analysis of donor attitudes and attributesR Yomtovian, J Ceynar, J L Kepner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: a Pediatric Oncology Group studyR K Mulhern, J L Kepner, P R Thomas, et al.
Journal of Neuropathology and Experimental Neurology|October 9, 1999
Pediatric astrocytomas with monomorphous pilomyxoid features and a less favorable outcomeT Tihan, P G Fisher, J L Kepner, et al.
Genes, Chromosomes & Cancer|August 19, 1999
Chromosome arm 6q loss is the most common recurrent autosomal alteration detected in primary pediatric ependymomaD A Reardon, R E Entrekin, J Sublett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2001
Cyclophosphamide plus topotecan in children with recurrent or refractory solid tumors: a Pediatric Oncology Group phase II studyR L Saylors, K C Stine, J Sullivan, et al.
The American Journal of Surgical Pathology|September 16, 1998
Atypical teratoid/rhabdoid tumor of the central nervous system: a highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma: a Pediatric Oncology Group studyP C Burger, I T Yu, T Tihan, et al.
Journal of Neuro-Oncology|August 17, 1999
Topotecan for the treatment of recurrent or progressive central nervous system tumors - a pediatric oncology group phase II studyR P Kadota, C F Stewart, M Horn, et al.
Neuro-Oncology|March 27, 2001
Carboplatin is effective therapy for young children with progressive optic pathway tumors: a Pediatric Oncology Group phase II studyD H Mahoney, M E Cohen, H S Friedman, et al.
Journal of Neuropathology and Experimental Neurology|November 18, 2000
"Large cell/anaplastic" medulloblastomas: a Pediatric Oncology Group StudyH G Brown, J L Kepner, E J Perlman, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Controlled Clinical Trials|August 10, 1999
Group sequential designs for phase II trials with historical controlsM N Chang, J J Shuster, J L Kepner
QRB. Quality Review Bulletin|February 1, 1987
Predeposit autologous blood transfusion: an analysis of donor attitudes and attributesR Yomtovian, J Ceynar, J L Kepner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: a Pediatric Oncology Group studyR K Mulhern, J L Kepner, P R Thomas, et al.
Journal of Neuropathology and Experimental Neurology|October 9, 1999
Pediatric astrocytomas with monomorphous pilomyxoid features and a less favorable outcomeT Tihan, P G Fisher, J L Kepner, et al.
Genes, Chromosomes & Cancer|August 19, 1999
Chromosome arm 6q loss is the most common recurrent autosomal alteration detected in primary pediatric ependymomaD A Reardon, R E Entrekin, J Sublett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2001
Cyclophosphamide plus topotecan in children with recurrent or refractory solid tumors: a Pediatric Oncology Group phase II studyR L Saylors, K C Stine, J Sullivan, et al.
The American Journal of Surgical Pathology|September 16, 1998
Atypical teratoid/rhabdoid tumor of the central nervous system: a highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma: a Pediatric Oncology Group studyP C Burger, I T Yu, T Tihan, et al.
Journal of Neuro-Oncology|August 17, 1999
Topotecan for the treatment of recurrent or progressive central nervous system tumors - a pediatric oncology group phase II studyR P Kadota, C F Stewart, M Horn, et al.
Neuro-Oncology|March 27, 2001
Carboplatin is effective therapy for young children with progressive optic pathway tumors: a Pediatric Oncology Group phase II studyD H Mahoney, M E Cohen, H S Friedman, et al.
Journal of Neuropathology and Experimental Neurology|November 18, 2000
"Large cell/anaplastic" medulloblastomas: a Pediatric Oncology Group StudyH G Brown, J L Kepner, E J Perlman, et al.
Pageof 2